We are live on
!
Find out more
NC
Nicholas Company Portfolio holdings
AUM
$5.1B
1-Year Est. Return
8.43%
This Fund
S&P 500
This Quarter
Est. Return
+10.68%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$6.14B
AUM Growth
+$468M
(+8.2%)
Cap. Flow
-$55.6M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
19.99%
Holding
245
New
12
Increased
50
Reduced
115
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$76.3M |
| 2 |
PPG Industries
PPG
|
+$37.4M |
| 3 |
A.O. Smith
AOS
|
+$25M |
| 4 |
PayPal
PYPL
|
+$22.7M |
| 5 |
PagSeguro Digital
PAGS
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$50.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
| 3 |
Comcast
CMCSA
|
+$30.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$21.7M |
| 5 |
ALC
ASSISTED LIVING CONCEPTS INC NEW CL A COM STK (NV)
ALC
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.23% |
| 2 | Healthcare | 16.33% |
| 3 | Financials | 14.69% |
| 4 | Industrials | 12.83% |
| 5 | Consumer Discretionary | 12.5% |
Similar funds
VT
CS
EIC
AC
CIA
TAM
CTC
BG
Nicholas Company's Q4 2021 Portfolio in Review
As of Q4 2021, Nicholas Company held 245 positions worth $6.14B, up 8.2% from $5.68B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Nicholas Company's Q4 2021 filing shows 12 new, 50 increased, 115 reduced and 15 closed positions. Its largest new stake was Ulta Beauty: 196,435 shares worth $81M. The largest sale was Coca-Cola, an estimated $50.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Nicholas Company's largest Q4 2021 buy was Ulta Beauty: 196,435 shares worth $81M.
- Nicholas Company added most to PayPal in Q4 2021, an estimated $22.7M increase.
- Nicholas Company's biggest Q4 2021 reduction was Coca-Cola, cutting an estimated $50.6M.
- Nicholas Company fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $34.1M.
- Nicholas Company's ten largest holdings make up 20% of its $6.14B portfolio in Q4 2021.
- Nicholas Company opened 12 new positions and closed 15 in Q4 2021.
- Nicholas Company's portfolio value rose 8.2% quarter-over-quarter to $6.14B.
Based on Nicholas Company's 13F filing for Q4 2021, filed 11 Feb 2022.